Intermountain Precision Genomics Launches Antidepressant PGx Panels Developed on Agena MassARRAY®

NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the lab’s first pharmacogenomics test intended to help physicians use DNA to find the right antidepressants to prescribe to patients. It is also the initial step in a strategy to grow beyond precision oncology and offer genomic assays targeting a wider array of diseases.

View the Full Press Release [PDF]